Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Chronic low-grade inflammation in vegetarians and vegans: Biomarker evidence and methodological considerations.

Created on 24 Jun 2026

Authors

Ines Peremin, Goran Gajski, Marko Gerić, Ivone Jakaša

Published in

Advances in clinical chemistry. Volume 134. Pages 109-152. Epub Apr 15, 2026.

Abstract

The association between vegetarian and vegan dietary patterns and chronic low-grade inflammation represents a growing area within nutritional epidemiology, with potential implications for lifestyle-based prevention and management of non-communicable diseases. Although recent meta-analyses of cross-sectional studies conducted over the past 25 years suggest a trend toward lower levels of inflammatory biomarkers among vegetarians compared to non-vegetarians, the strength of this evidence remains limited. This chapter offers a state-of-the-art overview of this topic, providing a brief summary of key inflammatory biomarkers, assay technologies, and analytical considerations. It advocates for the use of high-sensitivity, high-throughput multiplex platforms to assess C-reactive protein as a clinically relevant marker, complemented by broader cytokine panels, to more precisely capture subtle differences across distinct dietary groups. Special emphasis is placed on the critical evaluation of findings from cross-sectional studies and related meta-analyses, with particular attention to their inherent methodological limitations.

PMID:
42336498
Bibliographic data and abstract were imported from PubMed on 24 Jun 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 1
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement